New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A2924

Introduced
2/28/22  

Caption

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

Impact

The proposed master plan is intended to enhance various aspects of public awareness and service delivery regarding Alzheimer's disease. This includes improving healthcare quality, promoting sustainable funding, and fostering environments that enable individuals with Alzheimer's to live in community settings designed for their needs. Specific measures within the plan will support caregiver efforts, develop affordable housing options, and prevent exploitation and abuse of affected individuals. The bill emphasizes a shift towards more person-centered care models that prioritize quality of life and community integration.

Summary

Assembly Bill A2924 aims to establish the 'New Jersey Alzheimer's Disease Master Plan Study Commission' within the Department of Human Services. This commission will consist of 15 members, including state legislators and professionals in the field of Alzheimer's care. Its primary responsibility is to develop a comprehensive master plan aimed at addressing the needs of individuals diagnosed with Alzheimer's disease and related dementias, as well as their caregivers. The bill underscores the importance of multi-faceted solutions to improve outcomes not only for patients but also for families affected by this condition.

Contention

Although the bill presents a progressive approach to addressing the challenges posed by Alzheimer's disease, potential areas of contention include the allocation of funds necessary to implement the master plan effectively. Skeptics may raise questions about the state's capability to sustain the required funding levels for long-term effectiveness. Additionally, ensuring that the appointed commission members represent a diverse array of perspectives, including those of caregivers, health professionals, and people directly affected by Alzheimer's, may pose challenges in achieving balanced representation and community input throughout the planning process.

Companion Bills

NJ S1242

Same As Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

Previously Filed As

NJ A1557

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ S1243

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ A972

Establishes New Jersey Forensic Science Planning Commission.

NJ S458

Establishes New Jersey Forensic Science Planning Commission.

NJ A4930

Establishes "Kidney Disease Study Commission."

NJ S4237

Establishes "Kidney Disease Study Commission."

NJ A2631

Establishes "Long-Term Care Facility Infectious Disease Preparedness and Home Health Care Study Commission."

NJ S2751

Establishes New Jersey Commission on Health Equity.

NJ AJR161

Establishes New Jersey Pancreatic Cancer Commission.

NJ A3377

Establishes New Jersey-India Commission.

Similar Bills

NJ S1243

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ A1557

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ S1250

Requires DHS to establish Alzheimer's disease public awareness campaign.

WV HB4474

Extending the Alzheimer’s Disease and Other Dementia Advisory Council sunset date.

WV SB604

Extending Alzheimer's Disease and Other Dementia Advisory Council sunset date

HI SCR203

Requesting The University Of Hawaii To Explore The Feasibility Of Establishing An Alzheimer's Disease Research Center And Identify The Requirements For Receiving Federal Funding From The National Institute On Aging For Alzheimer's Disease Research.

HI HR30

Requesting The University Of Hawaii To Explore The Feasibility Of Establishing An Alzheimer's Disease Research Center And Identify The Requirements For Receiving Federal Funding From The National Institute On Aging For Alzheimer's Disease Research.

HI SR163

Requesting The University Of Hawaii To Explore The Feasibility Of Establishing An Alzheimer's Disease Research Center And Identify The Requirements For Receiving Federal Funding From The National Institute On Aging For Alzheimer's Disease Research.